אביליפיי 30 מ"ג - Abilify 30 mg
×××ר××
×צפ××× ×××××¢ ××ר×× ×ר×פ××× ×ש ××××× ×¡ ××ש××× ×. ×× ××× × ×¨×©×× ××× ×¡ ××רש×× ×ר×פ××× ××× ×©× ×קצ××¢×ת רפ×××××.
ש××× ×× !
×ת×ר××: 1.7.2016 (× ×××§ ×××ר×× × ×-15/11/2025) ×תק××× ××××¢× ×× ×©××××§ ×תר××¤× ××פסק ×צ××ת×ת.
×ת×ר××: 1.7.2016 (× ×××§ ×××ר×× × ×-15/11/2025) ×תק××× ××××¢× ×× ×©××××§ ×תר××¤× ××פסק ×צ××ת×ת.
××§×ר: ××©×¨× ××ר×××ת - ××××¢×ת ×¢× ×פסקת ש××××§ תר×פ×ת
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× | ||||||
|---|---|---|---|---|---|---|
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | N05AX Other antipsychotics | |||||
| ×ר××× ×¤×¢×× (ATC5) | Aripiprazole 30MG âN05AX12 | |||||
| צ×רת ××ª× | פ××× - PER OS | |||||
| צ×רת ××× ×× | ×××××, TABLETS ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | |||||
| ×ת×××× | Abilify is indicated for the treatment of schizophrenia. And for the treatment of moderate to severe manic episodes in Bipolar I disorder and for the prevention of a new manic episode in patient who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment. | |||||
× ×ª×× × ×¡× [ ×צ×× ]
| ||||||
| ×ת××ת ××× ×× | Posology and method of administration | |||||
| ×ת××××ת × ×× | Contraindications | |||||
| ת×פע×ת ××××× | Undesirable effects | |||||
| ת××××ת ××× ×ª×¨×פת××ת | Interaction with other medicinal products and other forms of interaction | |||||
| ש×××ש ×××ר××× ××× ×§× | Pregnancy and Lactation | |||||
| פר××§×××× ×××§× | Pharmacodynamic Properties | |||||
| פר××§××§×× ×××§× | Pharmacokinetic Properties | |||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
Â
| |||||
| ×¢××× ×צר×× |  |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| ×××××פ×× 30 ×"× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | BRISTOL MYERS SQUIBB S.R.L., ITALY |
| ×©× ××¢× ×ר×ש×× | BRISTOL - MYERS SQUIBB, ISRAEL |
| ר×ש××× | ת×ר×× ××ש×: 09/2009. ר×ש××× ×ת×ר××: 01/2015 |
| ת×ר×× ×¢×××× ××ר×× | 1.7.2016 (× ×××§ ×××ר×× × ×-15/11/2025) |